Biotech Values

[mcbio]

Re: BIOD

Here is my list of candidates:

1. BiTE antibody/immunotherapy: MITI, CLDX
2. Generic/biosimilar/biobetter: PLX, MNTA
3. Ultrafast insulin: HALO, BIOD
4. Small molecule kinase inhibitor: ARRY, PCYC, EXEL
5. Antibody conjugate: IMGN, SGEN
5. Drug delivery/modification of existing drug: NKTR, HALO
6. Established small/mid cap: BMRN, ONXX

Curious to hear more of your thoughts on BIOD given that I see its market cap is under $60M. This is a name I've never followed though I see there was some discussion last year on the board. What are the key pros and cons for the stock? Looks like they're having to re-do Phase 3 trials for their ultrafast insulin; is that right? After a quick look, looks like they have roughly a year of cash on hand so they may need to do a financing soon I assume. Any buzz on partnering in lieu of any financing?